The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD study. - Burisch J; Bergemalm D; Halfvarson J; Domislovic V; Krznaric Z; Goldis A; Dahlerup JF; Oksanen P; Collin P; de Castro L; Hernandez V; Turcan S; et al. (United European gastroenterology journal, 2020)